Market Risers: Accrol Group Holdings PLC, Admiral Group plc, Ashtead Group plc, AstraZeneca plc

Accrol Group Holdings plc
[shareaholic app="share_buttons" id_name="post_below_content"]

The trading price for Accrol Group Holdings PLC with EPIC code: LON:ACRL has risen 3.63% or 0.8 points during the course of today’s session so far. Buyers have remained positive during the session. The periods high has already touched 22.84 while the low for the session was 22.8. The number of shares traded by this point in time totalled 849 with the daily average number around 417,979. A 52 week share price high is 151 equating to 129 points difference from the previous days close and the 52 week low at 0.42 which is a variance of 21.58 points. Accrol Group Holdings PLC has a 20 SMA of 22.48 with a 50 day moving average now at 23.16. The market capitalisation currently stands at £37.66m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Accrol Group Holdings PLC being recorded at Wednesday, July 18, 2018 at 1:12:13 PM GMT with the stock price trading at 22.8 GBX.

 

The stock price for Admiral Group plc EPIC code: LON:ADM has risen 1.42% or 27.75 points throughout the session so far. Traders have remained optimistic during this period. The period high was 1991 and hitting a low of 1958.5. The amount of shares exchanged has so far reached 240,979 while the average shares exchanged is 690,991. The 52 week high is 2184 amounting to 223.5 points different to the previous business close and a 52 week low sitting at 1766 is a variance of 194.5 points. Admiral Group plc now has a 20 SMA of 1823.4 and a 50 day moving average now of 1897.56. The market cap now stands at £5,721.01m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Admiral Group plc being recorded at Wednesday, July 18, 2018 at 1:48:25 PM GMT with the stock price trading at 1988.25 GBX.

 

Shares of Ashtead Group plc ticker lookup code: LON:AHT has stepped up 1.48% or 35 points throughout today’s trading session so far. Buyers seem confident throughout the trading session. The period high has peaked at 2403 dipping to 2376. The total volume of shares exchanged through this period comes to 597,368 while the average shares exchanged is 2,487,157. The 52 week high for the share price is 2441 amounting to 82 points different to the previous business close and a 52 week low sitting at 1542 is a variance of 817 points. Ashtead Group plc has a 20 day moving average of 2299.6 and now the 50 day moving average at 2324.56. The current market cap is £11,792.56m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Ashtead Group plc being recorded at Wednesday, July 18, 2018 at 1:48:39 PM GMT with the stock price trading at 2394 GBX.

 

Shares of AstraZeneca plc ticker code: LON:AZN has gained 1.02% or 56.37 points during today’s session so far. Market buyers are a positive bunch during the session. The high for the period has peaked at 5658.37 while the low for the session was 5580. The total volume of shares exchanged so far has reached 950,945 whilst the daily average number of shares exchanged is just 2,125,729. A 52 week share price high is 5658.37 amounting to 107.37 points difference from the previous days close and putting the 52 week low at 4260 a difference of some 1291 points. AstraZeneca plc has a 20 SMA of 5320.75 and now the 50 day MA at 5370.67. This puts the market cap at £71,689.68m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Wednesday, July 18, 2018 at 1:48:49 PM GMT with the stock price trading at 5607.37 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
Ashtead Group plc announces a $1.5bn share buyback arrangement with Barclays Bank, aiming to reduce share capital within 18 months.
Ashtead Group Plc reports a 6% growth in rental revenue for H1 2024 and revises annual guidance, highlighting Sunbelt 4.0 strategic milestones.
AstraZeneca's Imfinzi receives FDA approval for limited-stage small cell lung cancer, marking a significant breakthrough in extending patient survival.

Search

Search